03:25 AM EDT, 05/23/2024 (MT Newswires) -- Oxana Beskrovnaya, Chief Scientific Officer, on May 20, 2024, sold 30,426 shares in Dyne Therapeutics ( DYN ) for $1,002,751. Following the Form 4 filing with the SEC, Beskrovnaya has control over a total of 149,647 shares of the company, with 149,647 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000095017024063737/xslF345X03/ownership.xml

Price: 31.75, Change: +0.22, Percent Change: +0.70